Skip to content

10-QAccepted Nov 17, 4:06 PM ET

RespireRx Pharmaceuticals Inc. 10-Q

RespireRx Pharmaceuticals Inc.

Accepted (ET)

4:06 PM

Nov 17, 2023

Filed

Nov 17, 2023

Documents

55

Size

7.6 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.